Network origin in Arthur M. Krieg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 25 | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA
24
| Subsidiary | Pharmaceuticals: Major | 24 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland.
11
| Extinct | Miscellaneous Commercial Services | 11 |
| Subsidiary | Biotechnology | 6 | |
| Public Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Arthur M. Krieg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Director/Board Member Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member General Counsel Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Graduate Degree Masters Business Admin | |
| Princeton University | College/University | Director/Board Member Director/Board Member Corporate Officer/Principal Undergraduate Degree | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Investor | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Basel | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Chief Administrative Officer Chief Executive Officer | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a venture capital subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Founder Founder Founder | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Autolus Holdings (UK) Ltd.
 Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Part of Autolus Therapeutics Plc, Autolus Holdings (UK) Ltd. is a holding British company that operates subsidiaries engaged in pharmaceutical research and development activities. The company is based in London, UK and was founded in 2018. | Biotechnology | Director/Board Member Director/Board Member | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Chief Executive Officer | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| ARQULE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
| Suffolk University | College/University | Masters Business Admin Masters Business Admin | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Avoro Capital Advisor LLC
 Avoro Capital Advisor LLC Investment ManagersFinance Avoro Capital Advisor LLC (AVCAP) is a SEC-registered investment advisor and hedge fund management subsidiary of Avoro Capital LP. The firm was founded by Corey Goodman in 2009 as venBio Select Advisor LLC. In 2019, a strategic transaction was closed whereby venBio Select Advisor LP entered into an agreement to sell its wholly-owned subsidiary, venBio Select Advisor LLC, the investment manager of the venBio Select Funds, to a newly-formed holding company, Avoro Capital LP. Headquartered in New York, AVCAP provides investment advice and management to privately placed investment funds and separately managed account for high net-worth individuals. | Investment Managers | Chief Investment Officer Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Virginia Darden School of Business | College/University | Director/Board Member Masters Business Admin | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Chief Executive Officer | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal |
Statistics
International
| United States | 42 |
| United Kingdom | 8 |
| Ireland | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 19 |
| Finance | 9 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 437 |
| Corporate Officer/Principal | 184 |
| Independent Dir/Board Member | 103 |
| Chairman | 96 |
| Undergraduate Degree | 57 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Powell | 48 |
| Jean-Francois Formela | 47 |
| Anthony Evnin | 46 |
| Corey Goodman | 35 |
| Kurt von Emster | 34 |
| Robert Mark Weisskoff | 34 |
| Paul Brooke | 32 |
| Daniel Lynch | 32 |
| Nilesh Kumar | 26 |
| Robert M. Forrester | 25 |
| James Edward Thomas | 25 |
| Thomas O. Hecht | 24 |
| Robert Hugin | 24 |
| John Berriman | 24 |
| Patrick J. Langlois | 23 |
- Stock Market
- Insiders
- Arthur M. Krieg
- Company connections
